Re-balancing cellular energy substrate metabolism to mend the failing heart

Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165579. doi: 10.1016/j.bbadis.2019.165579. Epub 2019 Oct 31.

Abstract

Fatty acids and glucose are the main substrates for myocardial energy provision. Under physiologic conditions, there is a distinct and finely tuned balance between the utilization of these substrates. Using the non-ischemic heart as an example, we discuss that upon stress this substrate balance is upset resulting in an over-reliance on either fatty acids or glucose, and that chronic fuel shifts towards a single type of substrate appear to be linked with cardiac dysfunction. These observations suggest that interventions aimed at re-balancing a tilted substrate preference towards an appropriate mix of substrates may result in restoration of cardiac contractile performance. Examples of manipulating cellular substrate uptake as a means to re-balance fuel supply, being associated with mended cardiac function underscore this concept. We also address the molecular mechanisms underlying the apparent need for a fatty acid-glucose fuel balance. We propose that re-balancing cellular fuel supply, in particular with respect to fatty acids and glucose, may be an effective strategy to treat the failing heart.

Keywords: Cardiac contractile function; Diabetes; Energy homeostasis; Glucose; Heart failure; Long-chain fatty acids; Substrate balance.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • CD36 Antigens / antagonists & inhibitors
  • CD36 Antigens / metabolism
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use
  • Diet, High-Fat
  • Disease Models, Animal
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology*
  • Fatty Acids / metabolism
  • Glucose / metabolism
  • Heart / diagnostic imaging
  • Heart / drug effects
  • Heart / physiopathology*
  • Heart Failure / diagnosis
  • Heart Failure / pathology*
  • Heart Failure / physiopathology
  • Heart Failure / therapy
  • Humans
  • Magnetic Resonance Spectroscopy
  • Metabolic Networks and Pathways / drug effects
  • Metabolic Networks and Pathways / physiology
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology
  • Myocardium / cytology
  • Myocardium / pathology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Positron-Emission Tomography
  • Protein Processing, Post-Translational / drug effects
  • Protein Processing, Post-Translational / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • CD36 Antigens
  • Cardiotonic Agents
  • Fatty Acids
  • Glucose